References
- Hayes M. RAPH blood group system. Immunohematology 2014;30:6–10.
- Karamatic Crew V, Poole J, Bullock T, Burton N, Muniz-Diaz E, Daniels G. A new case and a novel molecular background in a MER2-negative (RAPH:–1) individual with anti-MER2 (abstract). Vox Sang 2012;103(Suppl 1):210–1.
- Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. bioRxiv 531210; doi: https://doi.org/10.1101/531210. Accessed 25 April 2020.
- Natarajan P, Peloso GM, Zekavat SM, et al. Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat Commun 2018;9:3391.
- Karamatic Crew V, Burton N, Kagan A, et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for correct assembly of human basement membranes in kidney and skin. Blood 2004;104:2217–23.
- Karamatic Crew V, Poole J, Long S, et al. Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2. Transfusion 2008;48:1912–6.
- Vahidnezhad H, Youssefian L, Saeidian AH, et al. Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy. Matrix Biol 2018;66:22–33.
- Moghaddam M, Naghi AA. Clinical significance of antibodies to antigens in the Raph, John Milton Hagen, I, Globoside, Gill, Rh-associated glycoprotein, FORS, JR, LAN, Vel, CD59, and Augustine blood group systems. Immunohematology 2018;34:85–90.
- Daniels GL, Tippett P, Palmer DK, Miller YE, Geyer D, Jones C. MER2: a red cell polymorphism defined by monoclonal antibodies. Vox Sang 1987;52:107–10.
- Burton NM, Daniels G. Structural modelling of red cell surface proteins. Vox Sang 2011;100:129–39.
- Wang Z, Wang C, Zhou Z, et al. CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis. Oncotarget 2016;7:60623–38.
- Fisher OM, Levert-Mignon AJ, Lehane CW, et al. CD151 gene and protein expression provides independent prognostic information for patients with adenocarcinoma of the esophagus and gastroesophageal junction treated by esophagectomy. Ann Surg Oncol 2016;23(Suppl 5):746–54.
- Medrano M, Communal L, Brown KR, et al. Interrogation of functional cell-surface markers identifies cd151 dependency in high-grade serous ovarian cancer. Cell Rep 2017;18: 2343–58.
- Zeng P, Wang YH, Si M, et al. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis. Oncotarget 2017;8:5592–602.
- Hwang S, Takimoto T, Hemler ME. Integrin-independent support of cancer drug resistance by tetraspanin CD151. Cell Mol Life Sci 2019;76:1595–604.
- Hochdorfer D, Florin L, Sinzger C, Lieber D. Tetraspanin CD151 promotes initial events in human cytomegalovirus infection. J Virol 2016;90:6430–42.
- Wong AH, Tran T. CD151 in respiratory diseases. Front Cell Dev Biol 2020;8:64.